Follow The Filings

LION Lionsgate Studios Cp

Lionsgate Studios Cp earnings company data as of 8:02 PM ET 10/22

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by LION's executives, directors and 10% owners in the last 12 months, from their Form 4s

All LION insider trades
  • None no insider bought on the open market
  • $2M sold by 4 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Mark H Rachesky MD Director
    Buy
    — 42.6M shares New stake
    Traded Jul 8 Filed Jul 10
  2. Mark H Rachesky MD Director
    Sale
    — 42.6M shares 91% of stake
    Traded Jul 8 Filed Jul 10
  3. Michael Raymond Burns Vice Chair
    Sale
    $196K 21,748 shares at $9.01 0.7% of stake
    Traded Dec 23, 2025 Filed Dec 29, 2025
  4. Jon Feltheimer CEO
    Sale
    $1.6M 195,000 shares at $8.28 5.3% of stake
    Traded Dec 22, 2025 Filed Dec 29, 2025
  5. Brian Goldsmith COO
    Sale
    $214K 25,000 shares at $8.54 1.7% of stake
    Traded Dec 18, 2025 Filed Dec 19, 2025

Also filed in the last 12 months, not counted as buying or selling: 61 stock grants and 41 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
8-K 5.07,9.01
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q LIONSGATE STUDIOS CORP. Q1 F27 FORM 10-Q
DEF 14A
DEFA14A
8-K 5.02,9.01
SCHEDULE 13D/A —
8-K 8.01
424B3
10-K FY 2026 FORM 10-K
8-K 2.02,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 5.02,9.01
424B3 424B3 JON FELTHEIMER AGREEMENT AMENDMENT

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.